Type 2 diabetes. Endocrine, nutritional and metabolic diseases
Conditions
Interventions
Intervention 1: intervention group: 1000 mg/day royal jelly tablet with breakfast for 8 weeks. Intervention 2: Placebo group: 1000 mg/day placebo tablet (containing edible paraffin) with breakfast for
Treatment - Drugs
Placebo
intervention group: 1000 mg/day royal jelly tablet with breakfast for 8 weeks
Placebo group: 1000 mg/day placebo tablet (containing edible paraffin) with breakfast for 8 weeks
Sponsors
Nutritional Research Center, Tabriz University Of Medical Sciences
Eligibility
Sex/Gender
Female
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 30-65 years old, BMI 25 until 30, having diabetes at least 6 months prior to the study, consumption of blood glucose lowering drugs Exclusion criteria: consumption of antioxidants supplements during last 3 month prior to the study, using insulin, pregnancy, lactation, acute renal disease, hypothyroidism, hyperthyroidism, allergy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum antioxidant status. Timepoint: 8weeks. Method of measurement: measurment of SOD,GPX-H,TAC,MDA.;Lipid profiles. Timepoint: 8 weeks. Method of measurement: TC, TG, LDL, HDL.;Insulin level. Timepoint: 8 weeks. Method of measurement: Serum level of insulin.;Blood glucose. Timepoint: 8 weeks. Method of measurement: fasting blood glucose.;Inflammatroy factors. Timepoint: 8 weeks. Method of measurement: HS-CRP. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anthropomethric indices. Timepoint: 8 Weeks. Method of measurement: Weight, Height, BMI.;Appetite. Timepoint: 8 weeks. Method of measurement: questionnaire.;Dietary intake. Timepoint: 8weeks. Method of measurement: 24 hours-food recal questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Reza Mahdavi
Nutritional Research Center, Tabriz University Of Medical Sciences
Outcome results
None listed